CELL INTELLIGENCE · 肿瘤细胞治疗研究

利妥昔单抗结合赋予 B 细胞淋巴瘤中 CD20⁺ 细胞外囊泡 NK 细胞激活特性

Rituximab Binding Endows CD20+ Extracellular Vesicles With NK Cell-Activating Properties in B Cell Lymphoma.

TRAIL 表达细胞外囊泡包裹的 PD-L1 抑制剂 ARB-272572 对肾细胞癌治疗的协同凋亡增敏作用

Synergistic apoptosis-sensitizing effect of PD-L1 inhibitor ARB-272572 encapsulated in TRAIL-expressing extracellular vesicles for renal cell carcinom

纳米医学在淋巴瘤精准管理中的进展：机制、诊断与治疗策略

Advancements in Nanomedicine for Precision Management of Lymphoma: Mechanisms, Diagnostics, and Therapeutic Strategies.

基于外泌体的方法在再生医学和眼恶性肿瘤靶向治疗中的应用：综合综述

Exosome-Based Approaches in Regenerative Medicine and Targeted Therapy for Eye Malignancies: A Comprehensive Review.

环磷酰胺：潜在肝肾毒性及间充质干细胞来源外泌体在 Wistar 大鼠中可能的治疗作用

Cyclophosphamide: Potential Hepatorenal Toxicity and the Possible Therapeutic Role of Mesenchymal Stem Cell-Derived Exosomes in Wistar Rats.

挖掘外泌体在白血病中的潜力：从分子信使到临床应用

Harnessing the power of exosomes in leukemia: from molecular messengers to clinical applications.

增强嵌合抗原受体-细胞外囊泡 (CAR-EV) 技术：癌症治疗的未来

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy.

人脐带间充质干细胞来源外泌体通过 let-7i-5p/Faslg 轴减轻肝脏缺血再灌注损伤

Exosomes derived from human umbilical cord mesenchymal stem cells attenuate hepatic ischaemia-reperfusion injury via the let-7i-5p/Faslg axis.

我们的研究结果表明，hucMSC-exos 通过抑制细胞凋亡减轻 HIRI。

淋巴瘤来源细胞外囊泡抑制 CAR-T 细胞功能

Lymphoma-derived extracellular vesicles inhibit CAR T cell function.

EGFR 突变肺腺癌细胞来源外泌体 miR-651-5p 通过下调 BCL2 表达诱导 CD8+ T 细胞凋亡

EGFR-Mutant Lung Adenocarcinoma Cell-Derived Exosomal miR-651-5p Induces CD8+ T Cell Apoptosis via Downregulating BCL2 Expression.